Bruce F. Mackler
Presidente presso Ethicann Pharmaceuticals, Inc.
Profilo
Bruce F.
Mackler is currently a Director at Nielsen BioSciences, Inc., a Director & President-Regulatory Operations at Anew Biotechnology, Inc., and the President & Director at Ethicann Pharmaceuticals, Inc. He previously worked as a Director, VP-Regulatory Affairs & Development at Immunomic Therapeutics, Inc. from 2011 to 2013, an Independent Director at CanniMed Therapeutics, Inc. from 2016 to 2018, and as a Principal at Monumental Venture Partners LLC.
Mackler received his undergraduate degree from Temple University in 1964, his doctorate from Oregon Health & Science University in 1970, and his graduate degree from The Pennsylvania State University in 1965.
He also received a graduate degree from Houston College of Law in 1979.
Posizioni attive di Bruce F. Mackler
| Società | Posizione | Inizio |
|---|---|---|
Anew Biotechnology, Inc.
 Anew Biotechnology, Inc. BiotechnologyHealth Technology Anew Biotechnology, Inc. operates as a biotechnology company. It develops and commercializes a portfolio of affordable, life-saving biologic drugs that are critical in the treatment of cancer. The company was founded by Joseph Sinkule in 2014 and is headquartered in Scottsdale, AZ. | Direttore/Membro del Consiglio | - |
Ethicann Pharmaceuticals, Inc.
 Ethicann Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ethicann Pharmaceuticals, Inc. manufactures pharmaceutical products. It focuses on the commercialization of cannabis-based ethical drugs. The company was founded by Brandon J. Price in 2018 and is headquartered in Toronto, Canada. | Presidente | 01/05/2018 |
Nielsen BioSciences, Inc.
 Nielsen BioSciences, Inc. BiotechnologyHealth Technology Nielsen BioSciences, Inc. manufactures biological products. Its products include candin HCP, spherusol HCP and spherusol patient. The company was founded by Harry S. Nielsen and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Bruce F. Mackler
| Società | Posizione | Fine |
|---|---|---|
| CANNIMED THERAPEUTICS INC | Direttore/Membro del Consiglio | 15/03/2018 |
Immunomic Therapeutics, Inc.
 Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Direttore/Membro del Consiglio | - |
Monumental Venture Partners LLC
 Monumental Venture Partners LLC Investment ManagersFinance Monumental Venture Partners LLC (Monumental Vntr Partners) is a venture capital firm co-founded by Roland Oliver and Jeff Friedman in 1999. The firm is headquartered in Mclean, Virginia. | Corporate Officer/Principal | - |
Formazione di Bruce F. Mackler
| Temple University (Pennsylvania) | Undergraduate Degree |
| Oregon Health & Science University | Doctorate Degree |
| The Pennsylvania State University | Graduate Degree |
| Houston College of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Monumental Venture Partners LLC
Monumental Venture Partners LLC Investment ManagersFinance Monumental Venture Partners LLC (Monumental Vntr Partners) is a venture capital firm co-founded by Roland Oliver and Jeff Friedman in 1999. The firm is headquartered in Mclean, Virginia. | Finance |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Health Technology |
Nielsen BioSciences, Inc.
Nielsen BioSciences, Inc. BiotechnologyHealth Technology Nielsen BioSciences, Inc. manufactures biological products. Its products include candin HCP, spherusol HCP and spherusol patient. The company was founded by Harry S. Nielsen and is headquartered in San Diego, CA. | Health Technology |
CanniMed Therapeutics, Inc.
 CanniMed Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology CanniMed Therapeutics, Inc. operated as a biopharmaceutical company. It offered plant biotechnology research and product development programs. The firm focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The company was founded on Oct 31st, 2016 and was headquartered in Saskatoon, Canada. | Health Technology |
Anew Biotechnology, Inc.
Anew Biotechnology, Inc. BiotechnologyHealth Technology Anew Biotechnology, Inc. operates as a biotechnology company. It develops and commercializes a portfolio of affordable, life-saving biologic drugs that are critical in the treatment of cancer. The company was founded by Joseph Sinkule in 2014 and is headquartered in Scottsdale, AZ. | Health Technology |
Ethicann Pharmaceuticals, Inc.
Ethicann Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ethicann Pharmaceuticals, Inc. manufactures pharmaceutical products. It focuses on the commercialization of cannabis-based ethical drugs. The company was founded by Brandon J. Price in 2018 and is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- Bruce F. Mackler
